Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of BI 14332 CL in Healthy Males
NCT02211989Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2006
- Primary completion
- Apr 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing BI 14332 CL with Placebo (2 arms). Primary endpoints: Number of patients with adverse events, Number of patients with clinically significant findings in vital signs and 3 more. Started Feb 2006; status: completed.
02
Drugs
BI 14332
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02211989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211989.